137 related articles for article (PubMed ID: 38851473)
21. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set.
Liu H; Tang T
Front Oncol; 2022; 12():952290. PubMed ID: 36276096
[TBL] [Abstract][Full Text] [Related]
22. Lactylation of METTL16 promotes cuproptosis via m
Sun L; Zhang Y; Yang B; Sun S; Zhang P; Luo Z; Feng T; Cui Z; Zhu T; Li Y; Qiu Z; Fan G; Huang C
Nat Commun; 2023 Oct; 14(1):6523. PubMed ID: 37863889
[TBL] [Abstract][Full Text] [Related]
23. Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy.
Lu X; Chen X; Lin C; Yi Y; Zhao S; Zhu B; Deng W; Wang X; Xie Z; Rao S; Ni Z; You T; Li L; Huang Y; Xue X; Yu Y; Sun W; Shen X
Adv Sci (Weinh); 2024 May; 11(18):e2309984. PubMed ID: 38430531
[TBL] [Abstract][Full Text] [Related]
24. Identification of cuproptosis-related biomarkers in dilated cardiomyopathy and potential therapeutic prediction of herbal medicines.
Bian R; Wang Y; Li Z; Xu X
Front Mol Biosci; 2023; 10():1154920. PubMed ID: 37168258
[No Abstract] [Full Text] [Related]
25. Dry and wet experiments reveal diagnostic clustering and immune landscapes of cuproptosis patterns in patients with ankylosing spondylitis.
Zhang P; Chen H; Zhang Y; Liu Y; Zhu G; Zhao W; Shang Q; He J; Zhou Z; Shen G; Yu X; Zhang Z; Chen G; Yu F; Liang D; Tang J; Liu Z; Cui J; Jiang X; Ren H
Int Immunopharmacol; 2024 Jan; 127():111326. PubMed ID: 38091828
[TBL] [Abstract][Full Text] [Related]
26. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma.
Chen Y; Tang L; Huang W; Zhang Y; Abisola FH; Li L
Front Endocrinol (Lausanne); 2022; 13():963220. PubMed ID: 36353226
[TBL] [Abstract][Full Text] [Related]
27. Identification of hub cuproptosis related genes and immune cell infiltration characteristics in periodontitis.
Liu S; Ge J; Chu Y; Cai S; Wu J; Gong A; Zhang J
Front Immunol; 2023; 14():1164667. PubMed ID: 37215133
[TBL] [Abstract][Full Text] [Related]
28. Cuproptosis/OXPHOS tendency prediction of prognosis and immune microenvironment of esophageal squamous cell carcinoma: Bioinformatics analysis and experimental validation.
Li L; Cheng H; Gong L; Huang Y; Yang J; Yan Q; Dai S; Wang J
Gene; 2024 Apr; 902():148156. PubMed ID: 38211899
[TBL] [Abstract][Full Text] [Related]
29. Copper(II)-Based Nano-Regulator Correlates Cuproptosis Burst and Sequential Immunogenic Cell Death for Synergistic Cancer Immunotherapy.
Luo Y; Luo X; Ru Y; Zhou X; Liu D; Huang Q; Linghu M; Wu Y; Lv Z; Chen M; Ma Y; Huang Y; Wang J
Biomater Res; 2024; 28():0039. PubMed ID: 38938647
[TBL] [Abstract][Full Text] [Related]
30. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease.
Wang D; Tian Z; Zhang P; Zhen L; Meng Q; Sun B; Xu X; Jia T; Li S
Biomed Pharmacother; 2023 Jul; 163():114830. PubMed ID: 37150036
[TBL] [Abstract][Full Text] [Related]
31. DLAT as a Cuproptosis Promoter and a Molecular Target of Elesclomol in Hepatocellular Carcinoma.
Gao F; Yuan Y; Ding Y; Li PY; Chang Y; He XX
Curr Med Sci; 2023 Jun; 43(3):526-538. PubMed ID: 37286711
[TBL] [Abstract][Full Text] [Related]
32. Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD-L1 for Enhanced Cancer Immunotherapy.
Guo B; Yang F; Zhang L; Zhao Q; Wang W; Yin L; Chen D; Wang M; Han S; Xiao H; Xing N
Adv Mater; 2023 Jun; 35(22):e2212267. PubMed ID: 36916030
[TBL] [Abstract][Full Text] [Related]
33. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer.
Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W
J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617
[TBL] [Abstract][Full Text] [Related]
34. Identification of Three Cuproptosis-specific Expressed Genes as Diagnostic Biomarkers and Therapeutic Targets for Atherosclerosis.
Chen YT; Xu XH; Lin L; Tian S; Wu GF
Int J Med Sci; 2023; 20(7):836-848. PubMed ID: 37324184
[TBL] [Abstract][Full Text] [Related]
35. [Effect of Qiju Dihuang Pill on serum levels of IFN-gamma and IL-4 in pregnant women of Gan-Shen yin deficiency syndrome].
Li YF; Zhu L; Wang SP; Gu J; Li DC
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Apr; 34(4):442-5. PubMed ID: 24812901
[TBL] [Abstract][Full Text] [Related]
36. SP1/CTR1-mediated oxidative stress-induced cuproptosis in intervertebral disc degeneration.
Chen X; Li K; Xiao Y; Wu W; Lin H; Qing X; Tian S; Liu S; Feng S; Wang B; Shao Z; Peng Y
Biofactors; 2024 Apr; ():. PubMed ID: 38599595
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma.
Wang B; Song Q; Wei Y; Wu X; Han T; Bu H; Tang S; Qian J; Shao P
Front Immunol; 2022; 13():948042. PubMed ID: 36275737
[TBL] [Abstract][Full Text] [Related]
38. Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer.
Zhou C; Li C; Zheng Y; Huang X
Front Oncol; 2022; 12():934076. PubMed ID: 36387247
[TBL] [Abstract][Full Text] [Related]
39. Elesclomol-copper synergizes with imidazole ketone erastin by promoting cuproptosis and ferroptosis in myelodysplastic syndromes.
Gao Y; Jin F; Zhang P; Zheng C; Zheng X; Xie J; Lu Y; Tong X; Du J; Zhang J; Wang Y
Biomed Pharmacother; 2024 Jun; 175():116727. PubMed ID: 38733771
[TBL] [Abstract][Full Text] [Related]
40. Pan-cancer profiles of the cuproptosis gene set.
Liu H
Am J Cancer Res; 2022; 12(8):4074-4081. PubMed ID: 36119826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
